Garrett, Joan T <br/><br/>
Resistance to HER2-directed antibodies and tyrosine kinase inhibitors: mechanisms and clinical implications.  [electronic resource] 

 -  Cancer biology & therapy  May 2011 
 - 793-800 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review 
<br/><br/><label>ISSN: </label>1555-8576 
<br/><br/><label>Standard No.: </label>10.4161/cbt.11.9.15045  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Drug Resistance, Neoplasm<br/>Humans<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Receptor, ErbB-2--antagonists & inhibitors